Clinical Trials Logo

Filter by:
NCT ID: NCT06004141 Terminated - Cancer Clinical Trials

Behavioral Coaching Intervention (Laguna Health) for Patients With Cancer

LAGUNA
Start date: August 30, 2023
Phase: N/A
Study type: Interventional

The overall goal of this study is to examine the feasibility, acceptability, and preliminary efficacy of using a behavioral coaching intervention (Laguna Health) for optimizing post-hospital discharge care in patients with cancer. Patients will be randomly assigned into one of the study groups: the behavioral coaching intervention (Laguna Health) + usual care versus usual care alone. The Laguna Health intervention has several components: 1. Post-Discharge Recovery Coaching with a Laguna Health recovery coach to help patients identify barriers to post-discharge recovery 2. Digital psycho-educational content tailored to the needs of patients with cancer 3. Personal healthcare summaries 4. Digital content and coaching on behavioral strategies to promote self-efficacy

NCT ID: NCT06002880 Terminated - Sensitivity, Tooth Clinical Trials

Clinical Evaluation of OBU When Used for Indirect Dental Restorations

Start date: July 14, 2023
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the clinical safety and performance of Optibond Universal (OBU), a single component universal dental adhesive intended for indirect dental restorations according to manufacturer's Instruction For Use.

NCT ID: NCT05996744 Terminated - COVID-19 Clinical Trials

Study of Obeldesivir in Children and Adolescents With COVID-19

Start date: December 26, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The goal of this clinical study is to learn more about the safety and tolerability of obeldesivir (ODV) in children and adolescents with coronavirus disease 2019 (COVID-19). The primary objectives are to evaluate the plasma pharmacokinetics (PK), safety and tolerability of ODV in pediatric participants with COVID-19.

NCT ID: NCT05993169 Terminated - Obesity, Morbid Clinical Trials

Body Composition Optimization Intervention RCT

Start date: September 15, 2023
Phase: N/A
Study type: Interventional

This study aims to identify if the addition of structured nutrition/weight loss counseling to patients at the bariatric clinic can increase the conversion from bariatric clinic to surgical candidacy from (the current) 11% to a goal of 20% by way of tracking their BIA measurements.

NCT ID: NCT05979415 Terminated - Parkinson Disease Clinical Trials

Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes

Start date: September 27, 2023
Phase: Phase 2
Study type: Interventional

This study will be conducted with In-clinic visits and treatment at home for each patient with established Parkinson's disease (PD) experiencing daily OFF episodes.

NCT ID: NCT05962710 Terminated - Diabetes Mellitus Clinical Trials

FreeStyle Libre 3 Continuous Glucose Monitoring System

Start date: January 27, 2023
Phase:
Study type: Observational

The purpose of this study is to characterize the FreeStyle Libre 3 Continuous Glucose Monitoring System performance with respect to YSI reference venous plasma sample measurements.

NCT ID: NCT05956496 Terminated - Gingival Recession Clinical Trials

Gingival Augmentation and Root Coverage With Superficial and Deep Cut Acellular Dermal Matrices

Start date: October 3, 2023
Phase: N/A
Study type: Interventional

This entire protocol involves procedures that are standard care and will randomize subjects to of one two routine care procedures. Patients needing root coverage for gingival recession will be enrolled.

NCT ID: NCT05954052 Terminated - Clinical trials for Autism Spectrum Disorder

A Study of Glutathione in Children With Autism Spectrum Disorder

Start date: July 1, 2019
Phase: Phase 4
Study type: Interventional

The aim of this study is to investigate if taking a supplement called Glutathione by mouth is safe and practical for children and teenagers with Autism Spectrum Disorder (ASD). The researchers plan to involve 24 individuals with ASD and give them oral Glutathione for 12 weeks.

NCT ID: NCT05943990 Terminated - Neoplasms Clinical Trials

Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Start date: December 21, 2020
Phase: Phase 1
Study type: Interventional

To assess the safety, tolerability and determine recommended phase 2 dose (RP2D) of GSK3845097 in HLA-A*02:01, HLA-A*02:05 and/or HLA-A*02:06 positive participants with New York esophageal squamous cell carcinoma (NY-ESO)-1 and/or Cancer testis antigen 2 (LAGE-1a) positive, previously treated, advanced (metastatic or unresectable) Synovial Sarcoma (SS) and Myxoid/Round Cell Liposarcoma (MRCLS).

NCT ID: NCT05936294 Terminated - Clinical trials for Right Bundle-Branch Block

Adaptive Cardiac Resynchronization Therapy in Patients With RBBB

Start date: September 15, 2017
Phase: N/A
Study type: Interventional

This study will address whether acute adaptive RV pacing in sinus rhythm patients with severe LV systolic dysfunction and RBBB is superior to no ventricular pacing, and is as effective as echocardiographically optimized biventricular (BIV) pacing based on Medtronic ECG belt and cardiac performance as assessed by the echocardiographic parameters of RV and LV function.